- Home
- CFBK vs OSUR Comparison
CFBK vs OSUR Comparison
Compare CFBK & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFBK | OSUR |
|---|---|---|
| Founded | 1892 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.7M | 256.6M |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CFBK | OSUR |
|---|---|---|
| Price | $34.79 | $3.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 35.7K | ★ 614.4K |
| Earning Date | 10-27-2026 | 11-09-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 30.58 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $7.47 | $5.46 |
| Revenue Next Year | $12.52 | $7.63 |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.10 | $2.08 |
| 52 Week High | $38.11 | $4.58 |
Technical Indicators
Market Signals| Indicator | CFBK | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 53.68 | 40.74 |
| Support Level | $33.51 | $2.78 |
| Resistance Level | $35.23 | $4.11 |
| Average True Range (ATR) | 0.91 | 0.24 |
| MACD | 0.10 | -0.07 |
| Stochastic Oscillator | 54.28 | 15.00 |
Price Performance
Historical ComparisonAbout CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.